Does anyone know when BMS contract ends?
- Thread starter anonymous
- Start date
-
- Tags
- None
<
It ends when I say it ends. Now get back to work you SLACKER!!!
Specialty reps could easily cover our primary care doctors. We already overlap with them anyway. So it's more about E and the length of time of remaining with the contract that equals job security, especially since we don't have a CV product in the pipeline that would come to fruition in a timely manner.
Does BMS and Pfizer plan to negotiate and renew the contract or is it just BMS after April 2024 until patent expiration? The BMS new CV alignment looks like it's heavily focused on Eliquis and not so much on its new product, just curious if that is why the heavy Eliquis presence, if they are loosing Pfizer overlays.
It would be helpful if we all had clarity on this important date. Thank you all for your input.
The USA patent runs out in late 2026. Generics are not likely to hit the market until April 2027. This is public knowledge.
Eliquis will be subject to price negotiations with Medicare soon which would more than likely take effect before the patent expiration. How much the price is reduced remains to be seen.
Part of the reason Part D expenditures are so high with Eliquis are the result of the high volume of patients who are on it. Aside from doughnut hole and beginning of the year deductible payments most Part D plans have Eliquis at a very reasonable branded co pay.
There’s no question that use of Eliquis in the Medicare population has saved Part A money in hospitalization costs due to fewer strokes and bleeds compared to the days when warfarin was the only option.
The E contract is the only reason this shithole is still a viable company..if you believe that a drug that's been out almost 12 years still needs help with promotion. Most of us want our severance payment so we can get the F out of here.
The “negotiated” (read extortion) price for Eliquis does not begin until Jan 2026, so the gravy train runs for 2 more years!